ArticleClinical cancer research : an official journal of the American Association for Cancer Research2010

A proteasome inhibitor, bortezomib, inhibits breast cancer growth and reduces osteolysis by downregulating metastatic genes.

Marci D Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.